Physician profile
Kunali Dalal
NPI 1770712234
$1,183.75
in general payments reported to CMS, 2019-2025
20 companies · $13.90 in 2025
The $13.90 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $96.39 · 2021: $99.98 · 2022: $737 · 2023: $237 · 2025: $13.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $221.20 | 2020-2022 | |
| Myovant Sciences INC. | $132.20 | 2022 | |
| Medtronic, INC. | $127.07 | 2022 | |
| Aspira Women'S Health INC | $94.38 | 2022 | |
| Abbvie INC. | $83.76 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $76.92 | 2023 | Myfembree |
| Exeltis, USA INC. | $71.79 | 2022-2023 | Slynd |
| Scynexis, INC. | $60.99 | 2022 | |
| Amarin Pharma, INC. | $52.09 | 2020 | |
| Daiichi Sankyo INC. | $51.39 | 2022-2023 | Injectafer |
| Astellas Pharma US INC | $35.82 | 2023 | Veozah, Myrbetriq |
| Pfizer INC. | $31.00 | 2022 | |
| Mayne Pharma Commercial LLC | $30.63 | 2022 | |
| Glaxosmithkline, LLC. | $30.00 | 2020 | |
| Agile Therapeutics, INC. | $15.09 | 2023 | Twirla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.05 | 2021 | |
| Therapeuticsmd, INC. | $14.83 | 2022 | |
| Kyowa Kirin, INC. | $13.90 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $13.36 | 2021 | |
| Organon LLC | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunali Dalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.